[go: up one dir, main page]

WO1992019627A3 - Phosphonates et phosphinates utilises comme agents anticancereux, anti-inflammatoires, antiallergiques et anti-myocardites - Google Patents

Phosphonates et phosphinates utilises comme agents anticancereux, anti-inflammatoires, antiallergiques et anti-myocardites Download PDF

Info

Publication number
WO1992019627A3
WO1992019627A3 PCT/CA1992/000165 CA9200165W WO9219627A3 WO 1992019627 A3 WO1992019627 A3 WO 1992019627A3 CA 9200165 W CA9200165 W CA 9200165W WO 9219627 A3 WO9219627 A3 WO 9219627A3
Authority
WO
WIPO (PCT)
Prior art keywords
group
head group
allergy
inflammatory
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CA1992/000165
Other languages
English (en)
Other versions
WO1992019627A2 (fr
Inventor
Hassan Salari
Robert Bittman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Publication of WO1992019627A2 publication Critical patent/WO1992019627A2/fr
Publication of WO1992019627A3 publication Critical patent/WO1992019627A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4081—Esters with cycloaliphatic alcohols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/303—Cycloaliphatic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075—Esters with hydroxyalkyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention se rapporte à la synthèse et à l'utilisation, comme agents thérapeutiques, d'un groupe de substances présentant un squelette de glycérol ou une structure de chaîne aliphatique lié(e) à un atome de phosphore ou à un groupe de tête polaire. Selon le groupe de tête polaire, la substance présente des caractéristiques anticancéreuses, anti-inflammatoires, anti-allergiques ou agissant contre les maladies cardiovasculaires. On décrit aussi des composés de la formule (I) et (II), où n vaut de 0 à 14 et R1 représente un groupe alkyle C12-C20, R2 représente un groupe méthyle et R3 représente un groupe de tête d'analogue d'inositol, un groupe (CH2)mN+(CH3)3 où m vaut de 2 à 10, un groupe de tête de sérine ou un groupe de tête d'éthanolamine, ou de la formule (III) où R1 et R2 sont tels que décrits ci-dessus, n = 0 ou 1, et R3 représente (CH2)mN+(CH3)3 (m=2-10). L'invention se rapporte en outre à la synthèse et à l'utilisation, comme agents thérapeutiques, de substances ne possédant pas de squelette de glycérol, mais qui présentent une structure de chaîne aliphatique directement liée à un atome de phosphore de la formule générale R-P(0)(0-) OR', où R représente un groupe alkyle à chaîne longue tel que hexadécyle ou octadécyle et R' représente un groupe de tête tel que choline, glycérol, inositol, éthanolamine ou sérine.
PCT/CA1992/000165 1991-04-25 1992-04-21 Phosphonates et phosphinates utilises comme agents anticancereux, anti-inflammatoires, antiallergiques et anti-myocardites Ceased WO1992019627A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69245291A 1991-04-25 1991-04-25
US692,452 1991-04-25

Publications (2)

Publication Number Publication Date
WO1992019627A2 WO1992019627A2 (fr) 1992-11-12
WO1992019627A3 true WO1992019627A3 (fr) 1993-05-13

Family

ID=24780645

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA1992/000165 Ceased WO1992019627A2 (fr) 1991-04-25 1992-04-21 Phosphonates et phosphinates utilises comme agents anticancereux, anti-inflammatoires, antiallergiques et anti-myocardites

Country Status (2)

Country Link
EP (1) EP0581793A1 (fr)
WO (1) WO1992019627A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9600194D0 (sv) * 1996-01-19 1996-01-19 Perstorp Ab A new chemical compound
WO2002067855A2 (fr) * 2001-02-21 2002-09-06 The Research Foundation Of The City University Of New York Enantiomeres d'alkyllysophosphonocholines non saturees et leur utilisation comme anti-neoplasiques
US20060116354A1 (en) * 2003-01-09 2006-06-01 Perkins Walter R Antineoplastic ether lipid compounds with modifications at the sn-3 carbon

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2619686A1 (de) * 1976-05-04 1977-11-24 Max Planck Gesellschaft Anti-tumormittel
EP0092190A2 (fr) * 1982-04-19 1983-10-26 Fujisawa Pharmaceutical Co., Ltd. Dérivés de phospholipides, procédé pour les préparer et compositions pharmaceutiques s'y rapportant
EP0108565A2 (fr) * 1982-11-08 1984-05-16 Takeda Chemical Industries, Ltd. Phospholipides, leur production et leur utilisation
US4515722A (en) * 1982-03-30 1985-05-07 Merck & Co., Inc. Phosphatidyl inositol analogs useful as anti-inflammatory/analgesic agents
US4640913A (en) * 1983-01-10 1987-02-03 American Cyanamid Company Phosphocholine derivatives having antihypertensive action
EP0338407A1 (fr) * 1988-04-19 1989-10-25 Hafslund Nycomed Pharma Aktiengesellschaft Nouvelles alkylphosphonoserines, procédés pour leur préparation, et substances pharmaceutiques les contenant
JPH0669088A (ja) * 1992-03-26 1994-03-11 Nec Kyushu Ltd 空調システム

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2619686A1 (de) * 1976-05-04 1977-11-24 Max Planck Gesellschaft Anti-tumormittel
US4515722A (en) * 1982-03-30 1985-05-07 Merck & Co., Inc. Phosphatidyl inositol analogs useful as anti-inflammatory/analgesic agents
EP0092190A2 (fr) * 1982-04-19 1983-10-26 Fujisawa Pharmaceutical Co., Ltd. Dérivés de phospholipides, procédé pour les préparer et compositions pharmaceutiques s'y rapportant
EP0108565A2 (fr) * 1982-11-08 1984-05-16 Takeda Chemical Industries, Ltd. Phospholipides, leur production et leur utilisation
US4640913A (en) * 1983-01-10 1987-02-03 American Cyanamid Company Phosphocholine derivatives having antihypertensive action
EP0338407A1 (fr) * 1988-04-19 1989-10-25 Hafslund Nycomed Pharma Aktiengesellschaft Nouvelles alkylphosphonoserines, procédés pour leur préparation, et substances pharmaceutiques les contenant
JPH0669088A (ja) * 1992-03-26 1994-03-11 Nec Kyushu Ltd 空調システム

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 114, 1991, Columbus, Ohio, US; abstract no. 82129h, BRACHWITZ, H. ET AL. page 767 ; *
CHEMICAL ABSTRACTS, vol. 117, 1992, Columbus, Ohio, US; abstract no. 90393s, RIES, U.J. ET AL. page 794 ; *
JOURNAL OF MEDICINAL CHEMISTRY vol. 34, no. 4, 1 April 1991, pages 1377 - 1383 MEYER, K.L. ET AL. *
JOURNAL OF MEDICINAL CHEMISTRY vol. 34, no. 4, 1 April 1991, pages 1408 - 1414 PIANTADOSI, C. ET AL. *
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY vol. 110, 1988, pages 2665 - 2666 YUAN, W. ET AL. *

Also Published As

Publication number Publication date
EP0581793A1 (fr) 1994-02-09
WO1992019627A2 (fr) 1992-11-12

Similar Documents

Publication Publication Date Title
KR960034178A (ko) 벤자제핀- 벤즈옥사제핀- 및 벤조티아제핀-n- 아세트산 유도체와 그 제조방법 및 그들을 함유한 약제학적 조성물
KR920018011A (ko) N-아실-α-아미노산 유도체
ES2102478T3 (es) Complejos de vanadio, su preparacion y composiciones farmaceuticas que los contienen.
ATE142198T1 (de) Vitamin-d-derivate und verfahren zur herstellung dieser verbindungen
KR910014365A (ko) 지질-선택성 산화방지제, 이의 제조방법 및 용도
ATE144517T1 (de) Neue erucyl-, brassidyl- und nervonylderivate
ES496392A0 (es) Un procedimiento para la produccion de un ester de coleste- rol
GB1536515A (en) Compositions containing silicon derivatives
ES2091057T3 (es) Composicion medicinal que mejora el metabolismo de los lipidos.
ATE64368T1 (de) Ester von mit pyrethrumsaeure verwandten cyclopropancarbonsaeuren, verfahren zur ihrer herstellung und ihre verwendung als parasitizide.
ES526787A0 (es) Un procedimiento de preparacion de una composicion lubricante de aceite lubricante mineral hidrocorretinado-compuesto olefinico alifatico-hidro carburo olefinico sulfurado.
EP0295304A4 (fr) Fluide de traction synthetique.
ATE109770T1 (de) Derivate der coffeinsäure und pharmazeutische zusammensetzungen, die sie enthalten.
EP0347930A3 (fr) Composition contenant du pigment métallique
WO1992019627A3 (fr) Phosphonates et phosphinates utilises comme agents anticancereux, anti-inflammatoires, antiallergiques et anti-myocardites
IL75891A (en) Antitussive and mucus regulating 2-substituted thiazolidines,their preparation and pharmaceutical compositions containing them
SE8600046L (sv) Anvendning av en esterforening som temporer baktericid och produkt innehallande esterforeningen
FR2707089B1 (fr) Nouveaux dérivés d'acide phosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
TW369531B (en) New taxoids, their preparation and pharmaceutical compositions containing them
FR2677023B1 (fr) Derives de coumarine hydrosolubles, leur preparation et leur utilisation comme substrat d'enzyme.
WO1994019025A3 (fr) Agents de contraste
PT1001944E (pt) Derivados de pirazina sua preparacao e os medicamentos que os contem
WO1987007635A1 (fr) Fluide de traction synthetique
KR910016659A (ko) 키랄 나프탈린디카복실레이트
Benech et al. Synthesis of New α-Ketophosphonates

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1992908170

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1992908170

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1992908170

Country of ref document: EP